Skip to main content
Top
Published in: Rheumatology International 6/2012

01-06-2012 | Original Article

High frequency of osteoporosis and fractures in women with dermatomyositis/polymyositis

Authors: Danieli Castro Oliveira de Andrade, Sonia Cristina de Magalhães Souza, Jozélio Freire de Carvalho, Liliam Takayama, Claudia Teresa Lobato Borges, José Mendes Aldrighi, Rosa Maria Rodrigues Pereira

Published in: Rheumatology International | Issue 6/2012

Login to get access

Abstract

Bone mass was only previously studied in juvenile dermatomyositis/polymyositis (DM/PM) patients. Therefore, the objective this study was to evaluate the prevalence of osteoporosis and fractures in adult DM/PM. Forty female DM/PM and 78 age-, gender-, and BMI-matched healthy controls were studied. Medical charts and clinical interviews of all patients were evaluated for demographic and clinical data, including disease activity, cumulative doses of glucocorticoid, menarche and menopause age, and fractures. Bone mineral density (BMD) using dual X-ray absorptiometry (DXA) were measured at lumbar spine (L1–L4) and hip. A decreased BMD in lumbar spine [0.902 (0.136) vs. 0.965 (0.141) g/cm2, P = 0.022] and femoral neck [0.729 (0.12) vs. 0.784 (0.127) g/cm2, P = 0.027] was observed in patients compared to controls. In addition, osteoporosis was more frequent in patients than in controls in both lumbar spine (20 vs. 3.8%, P = 0.007) and the femoral neck (27.5 vs. 10.3%, P = 0.016). Moreover, a high prevalence of fractures was found in patients in comparison to healthy subjects (17.9 vs. 5.1%, P = 0.040; OR = 3.92; CI 95%:1.07–14.33). Comparing DM/PM patients with (n = 17) and without (n = 23) osteoporosis/fractures, significant differences were observed regarding age [56.8 (11.9) vs. 48.3 (13.2) years, P = 0.042], weight [62.05 (13.56) vs. 71.51 (11.46) kg, P = 0.022] and frequency of post menopausal women (94.1 vs. 65.2%, P = 0.0002). No differences were observed concerning height, lean mass, total fat mass, disease activity, mean value of creatine kinase, cumulative glucocorticoid dose, or bisphosphonate use. Logistic regression analysis revealed a negative association between the presence of osteoporosis/fractures and weight (OR: 0.92, 95% CI: 0.85–0.98; P = 0.016). This is the first study that analyzed bone mass in adult DM/PM patients and it demonstrated that about one quarter of these patients have osteoporosis/fracture.
Literature
1.
go back to reference Yeap S, Fauzi A, Kong N et al (2009) Influences on bone mineral density in Malaysian premenopausal systemic lupus erythematosus patients on corticosteroids. Lupus 18:178–181PubMedCrossRef Yeap S, Fauzi A, Kong N et al (2009) Influences on bone mineral density in Malaysian premenopausal systemic lupus erythematosus patients on corticosteroids. Lupus 18:178–181PubMedCrossRef
2.
go back to reference Book C, Karlsson M, Akesson K et al (2008) Disease activity and disability but probably not glucocorticoid treatment predicts loss in bone mineral density in women with early rheumatoid arthritis. Scand J Rheumatol 37:248–254PubMedCrossRef Book C, Karlsson M, Akesson K et al (2008) Disease activity and disability but probably not glucocorticoid treatment predicts loss in bone mineral density in women with early rheumatoid arthritis. Scand J Rheumatol 37:248–254PubMedCrossRef
3.
go back to reference Souza RB, Borges CT, Takayama L et al (2006) Systemic sclerosis and bone loss: the role of the disease and body composition. Scand J Rheumatol 35:384–387PubMedCrossRef Souza RB, Borges CT, Takayama L et al (2006) Systemic sclerosis and bone loss: the role of the disease and body composition. Scand J Rheumatol 35:384–387PubMedCrossRef
4.
go back to reference Santiago RA, Silva CA, Caparbo VF et al (2008) Bone mineral apparent density in juvenile dermatomyositis: the role of lean body mass and glucocorticoid use. Scand J Rheumatol 37:40–47PubMedCrossRef Santiago RA, Silva CA, Caparbo VF et al (2008) Bone mineral apparent density in juvenile dermatomyositis: the role of lean body mass and glucocorticoid use. Scand J Rheumatol 37:40–47PubMedCrossRef
5.
go back to reference Michel BA, Bloch DA, Fries JF (1991) Predictors of fractures in early rheumatoid arthritis. J Rheum 18:804–808PubMed Michel BA, Bloch DA, Fries JF (1991) Predictors of fractures in early rheumatoid arthritis. J Rheum 18:804–808PubMed
6.
go back to reference Adinoff AD, Hollister JR (1983) Steroid-induced fractures and bone loss in patients with asthma. N Engl J Med 309:265–268PubMedCrossRef Adinoff AD, Hollister JR (1983) Steroid-induced fractures and bone loss in patients with asthma. N Engl J Med 309:265–268PubMedCrossRef
7.
go back to reference Van Staa TP, Leufkens HGM, Cooper C (2002) The epidemiology of corticosteroid-induced osteoporosis: a meta-analysis. Osteoporos Int 13:777–787PubMedCrossRef Van Staa TP, Leufkens HGM, Cooper C (2002) The epidemiology of corticosteroid-induced osteoporosis: a meta-analysis. Osteoporos Int 13:777–787PubMedCrossRef
8.
9.
go back to reference Wortmann RL (2001) Inflammatory and metabolic disease of muscle. In: Klipple JH, Crofford LJ, Stone JH, Weyand CM (ed) Primer on the rheumatic disease. Arthritis Foundation, Atlanta pp 369–376 Wortmann RL (2001) Inflammatory and metabolic disease of muscle. In: Klipple JH, Crofford LJ, Stone JH, Weyand CM (ed) Primer on the rheumatic disease. Arthritis Foundation, Atlanta pp 369–376
10.
go back to reference Clarke AE, Bloch DA, Medsger TA Jr et al (1995) A longitudinal study of functional disability in a national cohort of patients with polymyositis/dermatomyositis. Arthritis Rheum 38:1218–1224PubMedCrossRef Clarke AE, Bloch DA, Medsger TA Jr et al (1995) A longitudinal study of functional disability in a national cohort of patients with polymyositis/dermatomyositis. Arthritis Rheum 38:1218–1224PubMedCrossRef
11.
go back to reference Stewart WA, Acott PD, Salisbury SR et al (2003) Bone mineral density in juvenile dermatomyositis. Arthritis Rheum 48:2294–2298PubMedCrossRef Stewart WA, Acott PD, Salisbury SR et al (2003) Bone mineral density in juvenile dermatomyositis. Arthritis Rheum 48:2294–2298PubMedCrossRef
12.
go back to reference Alsufyani KA, Ortiz-Alvarez O, Cabral DA et al (2005) Bone mineral density in children and adolescents with systemic lupus erythematosus, juvenile dermatomyositis and systemic vasculitis: relationship to disease duration, cumulative corticosteroid dose, calcium intake and exercise. J Rheumatol 32:729–733PubMed Alsufyani KA, Ortiz-Alvarez O, Cabral DA et al (2005) Bone mineral density in children and adolescents with systemic lupus erythematosus, juvenile dermatomyositis and systemic vasculitis: relationship to disease duration, cumulative corticosteroid dose, calcium intake and exercise. J Rheumatol 32:729–733PubMed
13.
go back to reference Castro TC, Terreri MT, Szejnfeld VL et al (2005) Bone mineral density of Brazilian girls with juvenile dermatomyositis. Braz J Med Biol Res 38:309–313PubMedCrossRef Castro TC, Terreri MT, Szejnfeld VL et al (2005) Bone mineral density of Brazilian girls with juvenile dermatomyositis. Braz J Med Biol Res 38:309–313PubMedCrossRef
14.
go back to reference Bohan A, Peter JB (1975) Polymyositis and dermatomyositis (first of two parts). N Eng J Med 292:344–347CrossRef Bohan A, Peter JB (1975) Polymyositis and dermatomyositis (first of two parts). N Eng J Med 292:344–347CrossRef
15.
go back to reference Ponyi A, Borgulya G, Constantin T et al (2005) Functional outcome and quality of life in adlt patients with idiopathic inflammatory myositis. Rheumatology 44:83–88PubMedCrossRef Ponyi A, Borgulya G, Constantin T et al (2005) Functional outcome and quality of life in adlt patients with idiopathic inflammatory myositis. Rheumatology 44:83–88PubMedCrossRef
16.
go back to reference Lewiecki EM, Baim S, Binkley N et al (2008) Report of the international society for clinical densitometry 2007 adult position development conference and official positions. South Med J 101:735–739PubMedCrossRef Lewiecki EM, Baim S, Binkley N et al (2008) Report of the international society for clinical densitometry 2007 adult position development conference and official positions. South Med J 101:735–739PubMedCrossRef
17.
go back to reference van Geel TA, van den Bergh JP, Dinant GJ et al (2010) Individualizing fracture risk prediction. Maturitas 65:143–814PubMedCrossRef van Geel TA, van den Bergh JP, Dinant GJ et al (2010) Individualizing fracture risk prediction. Maturitas 65:143–814PubMedCrossRef
18.
go back to reference Kanis A, Oden A, Johansson H et al (2009) FRAX(R) and its applications to clinical practice. Bone 44:734–743PubMedCrossRef Kanis A, Oden A, Johansson H et al (2009) FRAX(R) and its applications to clinical practice. Bone 44:734–743PubMedCrossRef
19.
go back to reference Morin S, Tsang JF, Leslie WD (2009) Weight and body mass index predict bone mineral density and fractures in women aged 40 to 59 years. Osteoporos Int 20:363–370PubMedCrossRef Morin S, Tsang JF, Leslie WD (2009) Weight and body mass index predict bone mineral density and fractures in women aged 40 to 59 years. Osteoporos Int 20:363–370PubMedCrossRef
20.
go back to reference Almehed K, Forsblad d’Elia H, Kvist G, Ohlsson C, Carlsten H (2007) Prevalence and risk factors of osteoporosis in female SLE patients-extended report. Rheumatology (Oxford) 46:1185–1190CrossRef Almehed K, Forsblad d’Elia H, Kvist G, Ohlsson C, Carlsten H (2007) Prevalence and risk factors of osteoporosis in female SLE patients-extended report. Rheumatology (Oxford) 46:1185–1190CrossRef
21.
go back to reference El Maghraoui A, Rezqi A, Mounach A, Achemlal L, Bezza A, Ghozlani I (2010) Prevalence and risk factors of vertebral fractures in women with rheumatoid arthritis using vertebral fracture assessment. Rheumatology (Oxford) 49:1303–1310CrossRef El Maghraoui A, Rezqi A, Mounach A, Achemlal L, Bezza A, Ghozlani I (2010) Prevalence and risk factors of vertebral fractures in women with rheumatoid arthritis using vertebral fracture assessment. Rheumatology (Oxford) 49:1303–1310CrossRef
22.
go back to reference Gan WQ, Man SF, Senthilselvan A, Sin DD (2004) Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis. Thorax 59:574–580PubMedCrossRef Gan WQ, Man SF, Senthilselvan A, Sin DD (2004) Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis. Thorax 59:574–580PubMedCrossRef
23.
24.
go back to reference Tau C, Russo R (2007) Severe osteoporosis with vertebral crushes in juvenile dermatomyositis. Effect of oral alendronate therapy. Medicina (B Aires) 67:53–56 Tau C, Russo R (2007) Severe osteoporosis with vertebral crushes in juvenile dermatomyositis. Effect of oral alendronate therapy. Medicina (B Aires) 67:53–56
25.
go back to reference Mok CC, Cheung MY, Ho LY et al (2008) Risk and predictors of work disability in Chinese patients with systemic lupus erythematosus. Lupus 17:1103–1107PubMedCrossRef Mok CC, Cheung MY, Ho LY et al (2008) Risk and predictors of work disability in Chinese patients with systemic lupus erythematosus. Lupus 17:1103–1107PubMedCrossRef
26.
go back to reference Yee CS, Crabtree N, Skan J et al (2005) Prevalence and predictors of fragility fractures in systemic lupus erythematosus. Ann Rheum Dis 64:111–113PubMedCrossRef Yee CS, Crabtree N, Skan J et al (2005) Prevalence and predictors of fragility fractures in systemic lupus erythematosus. Ann Rheum Dis 64:111–113PubMedCrossRef
27.
go back to reference Li EK, Tam LS, Griffith JF et al (2009) High prevalence of asymptomatic vertebral fractures in Chinese women with systemic lupus erythematosus. J Rheumatol 36:1646–1652PubMedCrossRef Li EK, Tam LS, Griffith JF et al (2009) High prevalence of asymptomatic vertebral fractures in Chinese women with systemic lupus erythematosus. J Rheumatol 36:1646–1652PubMedCrossRef
28.
go back to reference Mendoza-Pinto C, García-Carrasco M, Sandoval-Cruz H et al (2009) Risk factors of vertebral fractures in women with systemic lupus erythematosus. Clin Rheumatol 28:579–585PubMedCrossRef Mendoza-Pinto C, García-Carrasco M, Sandoval-Cruz H et al (2009) Risk factors of vertebral fractures in women with systemic lupus erythematosus. Clin Rheumatol 28:579–585PubMedCrossRef
29.
go back to reference Borba VZ, Matos PG, da Silva Viana PR et al (2005) High prevalence of vertebral deformity in premenopausal systemic lupus erythematosus patients. Lupus 14:529–533PubMedCrossRef Borba VZ, Matos PG, da Silva Viana PR et al (2005) High prevalence of vertebral deformity in premenopausal systemic lupus erythematosus patients. Lupus 14:529–533PubMedCrossRef
30.
go back to reference Ørstavik RE, Haugeberg G, Uhlig T et al (2004) Self reported non-vertebral fractures in rheumatoid arthritis and population based controls: incidence and relationship with bone mineral density and clinical variables. Ann Rheum Dis 63:177–182PubMedCrossRef Ørstavik RE, Haugeberg G, Uhlig T et al (2004) Self reported non-vertebral fractures in rheumatoid arthritis and population based controls: incidence and relationship with bone mineral density and clinical variables. Ann Rheum Dis 63:177–182PubMedCrossRef
Metadata
Title
High frequency of osteoporosis and fractures in women with dermatomyositis/polymyositis
Authors
Danieli Castro Oliveira de Andrade
Sonia Cristina de Magalhães Souza
Jozélio Freire de Carvalho
Liliam Takayama
Claudia Teresa Lobato Borges
José Mendes Aldrighi
Rosa Maria Rodrigues Pereira
Publication date
01-06-2012
Publisher
Springer-Verlag
Published in
Rheumatology International / Issue 6/2012
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-011-1821-2

Other articles of this Issue 6/2012

Rheumatology International 6/2012 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.